Randomized Trial to Test Effect of Rivaroxaban or Apixaban on Menstrual Blood Loss in Women (RAMBLE)
Latest Information Update: 17 Nov 2023
At a glance
- Drugs Apixaban (Primary) ; Rivaroxaban
- Indications Venous thromboembolism
- Focus Adverse reactions
- Acronyms RAMBLE
Most Recent Events
- 18 Apr 2023 Status changed from recruiting to completed.
- 18 Apr 2023 Status changed from recruiting to completed.
- 04 Dec 2019 Planned End Date changed from 1 Dec 2025 to 1 Dec 2026.